Opioids and the oxytocin system: Mechanistic interactions altering maternal neuroplasticity
- 15 October 2026
- journal article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 38 (10)
Abstract
Due to the ongoing opioid epidemic, there has been a rise in the use of medications for opioid use disorder (MOUD) during pregnancy. This paper examines how buprenorphine (BUP), the new golden standard for MOUD, may disrupt maternal care through dysregulation of the oxytocin (OXT) system. OXT is central to parturition, lactation, caregiving, and coordinating activity across the maternal brain network (MBN), including the paraventricular (PVN) and supraoptic nucleus, medial preoptic area, and nucleus accumbens. The endogenous opioid system normally regulates OXT release, with μ‐opioid receptor (μOR) and κ‐opioid receptor (κOR) signaling influencing OXT neurons. BUP has a unique mechanism of action as it is a partial μOR agonist and a κOR antagonist, which may lead to complex interactions with endogenous opioids and subsequently the OXT system during pregnancy. In line with this, recent preclinical research suggests that BUP exposure during gestation results in reduced maternal motivation and inconsistent pup‐directed care in rodent models. Therefore, this paper will explore the possible underlying mechanisms of how BUP exposure may dysregulate the OXT system and thus play a role in the observed maternal care deficits. In particular, we propose that chronic BUP exposure dampens PVN OXT output, disrupts synchrony across the MBN, and constrains OXT‐driven neuroplasticity. Further, we will discuss the potential of postpartum OXT administration to restore maternal behaviors by re‐engaging OXT signaling and network activity in both clinical and preclinical models. By integrating receptor, network, and behavioral evidence, this review provides a framework for understanding BUP's impact on maternal care through oxytocinergic disruptions and for potential translational interventions.Keywords
This publication has 142 references indexed in Scilit:
- Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysisCochrane Database of Systematic Reviews, 2025
- Severe Maternal Morbidity Among Pregnant People With Opioid Use Disorder Enrolled in MedicaidJAMA Network Open, 2025
- Differential Effects of Prenatal Buprenorphine and Methadone on Postnatal Growth and Gene Expression in the Nucleus AccumbensDevelopmental Psychobiology, 2024
- Maternal care behavior and physiology moderate offspring outcomes following gestational exposure to opioidsDevelopmental Psychobiology, 2023
- Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018JAMA, 2021
- Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017JAMA, 2021
- Maternal responsivity and oxytocin in opioid‐dependent mothersDevelopmental Psychobiology, 2019
- The neurobiology of parenting: A neural circuit perspectiveBioEssays, 2016
- Plasticity of the Maternal Brain Across the LifespanNew Directions for Child and Adolescent Development, 2016
- Oxytocin and Maternal Brain PlasticityNew Directions for Child and Adolescent Development, 2016